Abera Bioscience AB (8WK) Stock Price & News

All values in SEK	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	4,92 m	-939,00 k	3,55 m	1,56 m
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5,70 m	7,85 m	9,30 m	7,11 m
Operating expense	5,79 m	7,96 m	9,39 m	7,19 m
Total operating expenses	5,79 m	7,96 m	9,39 m	7,19 m
Operating income	-867,00 k	-8,90 m	-5,83 m	-5,63 m
Other non operating income	-2,00 k	1,00 k	-	1,00 k
EBT including unusual items	-835,00 k	-8,80 m	-5,80 m	-5,56 m
EBT excluding unusual items	-835,00 k	-8,80 m	-5,80 m	-5,56 m
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	42,00 k	49,00 k	25,00 k	15,00 k
Net income	-835,00 k	-8,80 m	-5,80 m	-5,56 m
Net profit margin	-16,97%	936,85%	-163,13%	-355,66%
Earnings per share	-	-	-	-
Interest and investment income	34,00 k	69,00 k	40,00 k	67,00 k
Interest expense	-	-	-2,00 k	-
Net interest expenses	34,00 k	69,00 k	38,00 k	67,00 k
Depreciation and amortization charges	45,00 k	62,00 k	63,00 k	63,00 k
EBITDA	-822,00 k	-8,84 m	-5,77 m	-5,56 m
Gain or loss from assets sale	-	-	-	-

Finance